Business Daily Media

Men's Weekly

.

Constantly Strategical Planning High-Growth Sectors, Grand Pharma’s 2022 Interim Results Continue to Grow

HONG KONG SAR - Media OutReach - 11 August 2022- Grand Pharma (0512.HK, the "Company") announced its 2022 interim results recently. During the first half of 2022 (the "Period"), the Company recorded revenue of approximately HKD 5.21 billion, representing an increase of 14.1% YoY; net profit attributable to owners of the company of HKD 1.09 billion (excluding the changes in investment in Telix), representing an increase of 20.1% YoY.

During the period, the Company invested approximately HKD 1.60 billion in R&D and products.

During the first half of 2022, Grand Pharma fully promoted the coordinated development in its three core business areas, namely pharmaceutical technology, nuclear medicine anti-tumor diagnosis and treatment and cerebro-cardiovascular precision interventional diagnosis and treatment technology and biotechnology. It had a total of 19 R&D milestones, including 14 innovative products. The smooth progress in various business has brought a solid momentum to the steady growth of the Company's revenue in the first half of the year.

Specifically, during the Period, the Company recorded revenue of approximately HKD 3.60 billion in the field of pharmaceutical technology, representing an increase of 7.5% YoY. Among them, benefiting from the steady growth in the market promotion for blockbuster products "Rui Zhu" and "He Xue Ming Mu tablets", the Company's ophthalmology sector recorded a revenue of approximately HKD 660.88 million, representing an increase of 14.7% YoY. And its respiratory, severe and disease and anti-infection sector recorded revenue of approximately HKD 1,051.39 million, representing an increase of 10.7% YoY.

Grand Pharma recorded revenue of HKD 125.80 million in the field of nuclear medicine anti-tumor diagnosis and treatment and cerebro-cardiovascular precision interventional diagnosis and treatment technology, representing an increase of 36.2% YoY. During the first half of 2022, the Company's blockbuster innovative product in the nuclear medicine anti-tumor diagnosis and treatment sector Yttrium-90 resin microsphere injections has been commercialized in China. The product was recognized by many academicians, experts, doctors and patients. Since its commercialization, the Company has trained more than 300 doctors in 70 hospitals. Nearly 15 well-known hospitals have completed the hospital admission and team training, and two patients with liver cancer have achieved clinical care. It is reported that the product has bridged the gap in the local treatment of liver cancer in China, marking the arrival of a new international precision interventional treatment option in the field of liver malignancies in China.

It is also worth noting that the Company's biotechnology segment has achieved an increase of 32.0% YoY recording revenue of approximately HKD 1.49 billion. This was benefiting from the stable support from the supply chain and the increase in demand from international high-end markets in the sector of amino acid, which recorded revenue of approximately HKD 1.25 billion, representing an increase of 40.3% YoY.

Few days ago, Grand Pharma has announced the acquisition of 100% equity of Hubei Bafeng, making it the pharmaceutical company with the largest number of registered amino acid APIs in China, which tremendously expanded the Company's high-quality amino acid product portfolio, and further enhanced and improved the Company's market comprehensive competitiveness in the field of amino acid, driving the sustained and rapid growth of amino acid business.

Grand Pharma said that the Company will continue to uphold the operating concept of "Comprehensive Strengths, Innovation Leading and Global Expansion", constantly increase its investment in global innovative products and advanced technologies, fully leverage the Company's industrial strengths and R&D capabilities, and enrich and improve its product pipelines and industrial strategic plan to provide more advanced and diverse treatment solutions to patients worldwide, delivering on its promises for doctors and patients, and making significant contribution to the society.

Hashtag: #GrandPharma

News from Asia

Lee Kuan Yew School of Public Policy Releases Strategic Roadmap for ASEAN's 5G-AI Transformation

New Research Reveals US$130 Billion Economic Opportunity and Outlines Policy Framework to Accelerate Regional Digital Leadership by 2030SINGAPORE - Media OutReach Newswire - 22 July 2025 - The Le...

DFI Retail Group Holdings Limited Half-Year Results For The Six Months Ended 30 June 2025 And Announcement Of Special Dividend

Highlights 39% underlying earnings growth Increased contributions from associates, Health & Beauty and Food Health & Beauty delivered strong like-for-like (LFL...

HeyMax Acquires Hong Kong’s krip to Accelerate Regional Expansion into Loyalty and Rewards Market

HeyMax’s first acquisition fast-tracks its regional expansion, bringing over 6,000 credit card deals offered by over 3,000 merchants, and personalized loyalty experiences to consumers in Hong Kong ...

CUHK Faculty of Engineering: Advancing Innovation Through Research Excellence and Global Collaboration

HONG KONG SAR - Media OutReach Newswire - 23 July 2025 - The Faculty of Engineering at The Chinese University of Hong Kong (CUHK) continues to strengthen its position in global engineering educat...

Adecco Singapore Marks 40 Years of Enabling Talent and Business Growth

SINGAPORE - Media OutReach Newswire - 23 July 2025 - Adecco Singapore has officially commemorated its 40th anniversary with a stakeholder event held at the National Gallery Singapore. The occasion...

Samsung’s Solve for Tomorrow 2025 Youth Innovation Competition is Now On

SINGAPORE - Media OutReach Newswire - 23 July 2025 - Samsung Solve for Tomorrow 2025, the highly-anticipated youth innovation competition, is back for its ninth edition in Singapore! As the natio...

Jollibee Group Evolves its Corporate Brand to Help Power Global Growth

Brand update brings to life its global purpose and positioning as a unified group of brandsMANILA, PHILIPPINES - Media OutReach Newswire - 23 July 2025 - The Jollibee Group, one of the world's fas...

AECOM to enhance mobility across the Greater Bay Area by delivering the Hong Kong Section of Hong Kong–Shenzhen Western Rail Link (Hung Shui Kiu-Qianhai)

HONG KONG SAR - Media OutReach Newswire - 23 July 2025 - AECOM, the trusted global infrastructure leader, today announced that its joint venture with AtkinsRéalis has been awarded the consultancy ...

OCBC Hong Kong Unveils New Brand Campaign

Connected to “As One Group, OCBC Enables Aspiration All Across ASEAN and Greater China” Demonstrating the Unwavering Commitment in Realising Customer’s Aspirations HONG KONG SAR - Media...

X.me Foundation Empowers Global Expansion of the X.me Social Media Platform

SINGAPORE - Media OutReach Newswire - 23 July 2025 - X.me (https://x.me) is a social media platform where users can freely express themselves, share content, engage, and interact while earnin...

Baby boomers are driving development feasibility leading to larger apartments

As residential developers continue to grapple with feasibility issues on apartment projects, the sector is struggling to deliver volumes of new st...

Hays launches FY25/26 Salary Guide: ‘Salary Paradox’ deepens as pay rises fail Australians

Rising dissatisfaction with pay, progression and perks is fuelling a new wave of career change in FY25/26, as Australians demand more from employe...

Australian Businesses Still Stuck in the AI Hype Cycle

Data Governance Failures, ROI Gaps and Unclear Strategy Slowing Progress Despite artificial intelligence (AI) dominating headlines and boardroom ag...

How to ensure your manufacturing business survives international tariff turmoil

Optimising your operations in FY2026 will help you combat the challenges of a volatile trading environment. Up, down, in out…Since the commence...

Why Apptio is Enhancing Visibility into AI and Hybrid Cloud

AI investments have become a strategic priority for business with the mindset that if you're not using AI, you're falling behind. But according to...

Beyond borders: Building a scalable strategy for international hiring

For many Australian businesses, growth increasingly depends on thinking beyond local borders.  As wage pressures rise, and specialised talent pool...

Sell by LayBy